{"schema_version":"secwatch.filing_event.v1","accession":"0001174947-23-000151","form_type":"8-K","ticker":"CNMD","cik":"0000816956","company_name":"CONMED Corp","filed_at":"2023-02-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:48.168376+00:00","generated_at":"2026-06-20T03:02:26.544406+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"CONMED reports Q4 sales down 8.4%, adj. EPS down 60.7% on warehouse software disruption","bullets":["Q4 sales $250.9M (-8.4% YoY); GAAP EPS $0.86 vs $0.75 YoY; adjusted EPS $0.42 vs $1.07.","Full-year sales $1,045.5M (+3.4%); GAAP net loss per share $2.68; adjusted EPS $2.65 (-17.4%).","Q4 disruptions from new warehouse management system; management cites daily shipping now at or above historical rates.","2023 guidance: revenue $1.17B-$1.22B, adjusted EPS $3.20-$3.45, with FX headwind of $0.20-$0.25 per share.","Completed acquisitions of In2Bones (June 2022) and Biorez (Aug 2022), contributing ~240bps to full-year growth."],"urls":{"canonical":"https://secwatch.observer/filing/0001174947-23-000151","json":"https://secwatch.observer/filing/0001174947-23-000151.json","markdown":"https://secwatch.observer/filing/0001174947-23-000151.md","text":"https://secwatch.observer/filing/0001174947-23-000151.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/816956/000117494723000151/0001174947-23-000151-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/816956/000117494723000151/form8k-29345_cnmd.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T03:02:26.544406+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8358559ff8ab97b555636e61ee1c3ddf6d31094a","claim":"CONMED Corp reported the fourth quarter ended December 31, 2022 results: revenue $250.9 million, net income $26,584, EPS $0.86.","evidence_excerpt":"December 31, 2022. Fourth Quarter 2022 Highlights · Fourth quarter 2022 sales significantly impacted by the implementation of new warehouse management software. · Sales of $250.9 million decreased 8.4% year over year as reported and 7.0% in constant currency. Acquisitions contributed approximately 460 basis points of growth. · Domestic revenue decreased 3.9% year","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/816956/000117494723000151/0001174947-23-000151-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter ended December 31, 2022"},{"label":"Revenue","value":"$250.9 million"},{"label":"Net income","value":"$26,584"},{"label":"EPS","value":"$0.86"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}